Tuberculosis Skin Test Screening in the National Tuberculosis Program of Trinidad and Tobago
Globally, a quarter of the population is infected with tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i>. About 5–10% of latent TB infections (LTBI) progress to active disease during the lifetime. Prevention of TB and treating LTBI is a critical component of the World Health...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9032/8/3/236 |
id |
doaj-31c86b333eb946059d81726fccf20828 |
---|---|
record_format |
Article |
spelling |
doaj-31c86b333eb946059d81726fccf208282020-11-25T03:07:57ZengMDPI AGHealthcare2227-90322020-07-01823623610.3390/healthcare8030236Tuberculosis Skin Test Screening in the National Tuberculosis Program of Trinidad and TobagoVijay Kumar Chattu0Sateesh Sakhamuri1Shastri Motilal2Liam J. Pounder3Vasishma Kanita Persad4Neelmani Pierre5Shivannie Persad6Nikesha Pooran7Akua Mosi Pottinger8Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, CanadaDepartment of Clinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St Augustine, Trinidad and TobagoDepartment of Paraclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and TobagoDepartment of Clinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St Augustine, Trinidad and TobagoDepartment of Clinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St Augustine, Trinidad and TobagoDepartment of Clinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St Augustine, Trinidad and TobagoDepartment of Clinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St Augustine, Trinidad and TobagoDepartment of Clinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St Augustine, Trinidad and TobagoDepartment of Clinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St Augustine, Trinidad and TobagoGlobally, a quarter of the population is infected with tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i>. About 5–10% of latent TB infections (LTBI) progress to active disease during the lifetime. Prevention of TB and treating LTBI is a critical component of the World Health Organization’s (WHO) End TB Strategy. This study aims to examine the screening practices for prevention and treatment employed by the National Tuberculosis Program of Trinidad and Tobago in comparison to the WHO’s standard guidelines. A cross-sectional retrospective study was conducted from the TB registers (2018–2019) for persons aged 18 years and above with recorded tuberculin skin test reactions (TST). Bivariate comparisons for categorical variables were made using Chi-square or Fisher’s exact test. Binary logistic regression was used for exploring predictors of TST positivity with adjustment for demographic confounders in multivariable models. Of the total 1972 eligible entries studied, 384 (19.4%) individuals were tested positive with TST. TB contact screening (aOR 2.49; 95% CI 1.65, 3.75) and Bacillus Calmette–Guerin (BCG) vaccination status (aOR 1.66; 95% CI, 1.24 to 2.22) were associated with a positive TST reaction, whereas, preplacement screening failed to show such association when compared to those screened as suspect cases. The findings suggest that TB contact screening and positive BCG vaccination status are associated with TST positivity independent of age and gender.https://www.mdpi.com/2227-9032/8/3/236<i>Mycobacterium tuberculosis</i>World Health Organization (WHO)latent TB infection (LTB)tuberculin skin test (TST)Bacillus Calmette–Guerin (BCG)interferon-Gamma releasing assays (IGRAs) |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vijay Kumar Chattu Sateesh Sakhamuri Shastri Motilal Liam J. Pounder Vasishma Kanita Persad Neelmani Pierre Shivannie Persad Nikesha Pooran Akua Mosi Pottinger |
spellingShingle |
Vijay Kumar Chattu Sateesh Sakhamuri Shastri Motilal Liam J. Pounder Vasishma Kanita Persad Neelmani Pierre Shivannie Persad Nikesha Pooran Akua Mosi Pottinger Tuberculosis Skin Test Screening in the National Tuberculosis Program of Trinidad and Tobago Healthcare <i>Mycobacterium tuberculosis</i> World Health Organization (WHO) latent TB infection (LTB) tuberculin skin test (TST) Bacillus Calmette–Guerin (BCG) interferon-Gamma releasing assays (IGRAs) |
author_facet |
Vijay Kumar Chattu Sateesh Sakhamuri Shastri Motilal Liam J. Pounder Vasishma Kanita Persad Neelmani Pierre Shivannie Persad Nikesha Pooran Akua Mosi Pottinger |
author_sort |
Vijay Kumar Chattu |
title |
Tuberculosis Skin Test Screening in the National Tuberculosis Program of Trinidad and Tobago |
title_short |
Tuberculosis Skin Test Screening in the National Tuberculosis Program of Trinidad and Tobago |
title_full |
Tuberculosis Skin Test Screening in the National Tuberculosis Program of Trinidad and Tobago |
title_fullStr |
Tuberculosis Skin Test Screening in the National Tuberculosis Program of Trinidad and Tobago |
title_full_unstemmed |
Tuberculosis Skin Test Screening in the National Tuberculosis Program of Trinidad and Tobago |
title_sort |
tuberculosis skin test screening in the national tuberculosis program of trinidad and tobago |
publisher |
MDPI AG |
series |
Healthcare |
issn |
2227-9032 |
publishDate |
2020-07-01 |
description |
Globally, a quarter of the population is infected with tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i>. About 5–10% of latent TB infections (LTBI) progress to active disease during the lifetime. Prevention of TB and treating LTBI is a critical component of the World Health Organization’s (WHO) End TB Strategy. This study aims to examine the screening practices for prevention and treatment employed by the National Tuberculosis Program of Trinidad and Tobago in comparison to the WHO’s standard guidelines. A cross-sectional retrospective study was conducted from the TB registers (2018–2019) for persons aged 18 years and above with recorded tuberculin skin test reactions (TST). Bivariate comparisons for categorical variables were made using Chi-square or Fisher’s exact test. Binary logistic regression was used for exploring predictors of TST positivity with adjustment for demographic confounders in multivariable models. Of the total 1972 eligible entries studied, 384 (19.4%) individuals were tested positive with TST. TB contact screening (aOR 2.49; 95% CI 1.65, 3.75) and Bacillus Calmette–Guerin (BCG) vaccination status (aOR 1.66; 95% CI, 1.24 to 2.22) were associated with a positive TST reaction, whereas, preplacement screening failed to show such association when compared to those screened as suspect cases. The findings suggest that TB contact screening and positive BCG vaccination status are associated with TST positivity independent of age and gender. |
topic |
<i>Mycobacterium tuberculosis</i> World Health Organization (WHO) latent TB infection (LTB) tuberculin skin test (TST) Bacillus Calmette–Guerin (BCG) interferon-Gamma releasing assays (IGRAs) |
url |
https://www.mdpi.com/2227-9032/8/3/236 |
work_keys_str_mv |
AT vijaykumarchattu tuberculosisskintestscreeninginthenationaltuberculosisprogramoftrinidadandtobago AT sateeshsakhamuri tuberculosisskintestscreeninginthenationaltuberculosisprogramoftrinidadandtobago AT shastrimotilal tuberculosisskintestscreeninginthenationaltuberculosisprogramoftrinidadandtobago AT liamjpounder tuberculosisskintestscreeninginthenationaltuberculosisprogramoftrinidadandtobago AT vasishmakanitapersad tuberculosisskintestscreeninginthenationaltuberculosisprogramoftrinidadandtobago AT neelmanipierre tuberculosisskintestscreeninginthenationaltuberculosisprogramoftrinidadandtobago AT shivanniepersad tuberculosisskintestscreeninginthenationaltuberculosisprogramoftrinidadandtobago AT nikeshapooran tuberculosisskintestscreeninginthenationaltuberculosisprogramoftrinidadandtobago AT akuamosipottinger tuberculosisskintestscreeninginthenationaltuberculosisprogramoftrinidadandtobago |
_version_ |
1724668122080739328 |